Richard Saynor

CEO, Sandoz
· tracked since Aug 2026
Calls
1
Win Rate
-
return
-
Calls 1 1 Posts tracked · 1.0/day Posted today
Calls
7d 1
30d 1
90d 1
Win Rate - Long 1 Short 0
Win Rate
7d
30d
90d
Average Return - Long Return - Short Return -
Average Return
7d
30d
90d
Loading charts...
Result
Result
Sort
Theme Stance
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Aug 05
$79.32
-
Sandoz biosimilars driving strong growth.
Sandoz is in a golden decade with biosimilars revenue well ahead of 2030 targets, a rapidly expanding pipeline of 36 assets, strong cash generation, and leadership in generics.
Pharma & Biotech
Showing 1 of 1 calls · sorted by mentions

Richard Saynor has 1 trade ideas tracked on Buzzberg across 1 tickers since August 2026.